Hypercholesterolemia in the Malaysian Cohort Participants: Genetic and Non-Genetic Risk Factors

Hypercholesterolemia was prevalent in 44.9% of The Malaysian Cohort participants, of which 51% were Malay. This study aimed to identify the variants involved in hypercholesterolemia among Malays and to determine the association between genetic and non-genetic risk factors. This nested case–control study included 25 Malay participants with the highest low-density lipoprotein cholesterol (LDL-C, >4.9 mmol/L) and total cholesterol (TC, >7.5 mmol/L) and 25 participants with the lowest LDL-C/TC. Genomic DNA was extracted, and whole-exome sequencing was performed using the Ion ProtonTM system. All variants were annotated, filtered, and cross-referenced against publicly available databases. Forty-five selected variants were genotyped in 677 TMC Malay participants using the MassARRAY® System. The association between genetic and non-genetic risk factors was determined using logistic regression analysis. Age, fasting blood glucose, tobacco use, and family history of hyperlipidemia were significantly associated with hypercholesterolemia. Participants with the novel OSBPL7 (oxysterol-binding protein-like 7) c.651_652del variant had 17 times higher odds for hypercholesterolemia. Type 2 diabetes patients on medication and those with PCSK9 (proprotein convertase subtilisin/kexin type 9) rs151193009 had low odds for hypercholesterolemia. Genetic predisposition can interact with non-genetic factors to increase hypercholesterolemia risk in Malaysian Malays.

[1]  K. Chinna,et al.  Longitudinal assessment between lifestyle-related risk factors and a composite cardiovascular disease (CVD) risk index among adolescents in Malaysia , 2021, Scientific Reports.

[2]  K. Chung.  Advances in Understanding of the Role of Lipid Metabolism in Aging , 2021, Cells.

[3]  K. Yusoff,et al.  High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study , 2021, BMC Cardiovascular Disorders.

[4]  A. Ramli,et al.  Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment , 2021, Journal of atherosclerosis and thrombosis.

[5]  Kathryn M. Spitler,et al.  Aging and plasma triglyceride metabolism , 2020, Journal of Lipid Research.

[6]  T. Wong,et al.  Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease , 2019, Population Health Metrics.

[7]  Besral,et al.  The Effect of Lifestyle on Hypercholesterolemia , 2018, The Open Public Health Journal.

[8]  Astrid Gall,et al.  Ensembl 2018 , 2017, Nucleic Acids Res..

[9]  M. M. Mc Auley,et al.  LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge. , 2017, Medical hypotheses.

[10]  S. Karr.  Epidemiology and management of hyperlipidemia. , 2017, The American journal of managed care.

[11]  S. Humphries,et al.  Genetic Architecture of Familial Hypercholesterolaemia , 2017, Current Cardiology Reports.

[12]  S. Humphries,et al.  The UCL low-density lipoprotein receptor gene variant database: pathogenicity update , 2016, Journal of Medical Genetics.

[13]  E. Bruckert,et al.  Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature. , 2016, Clinical therapeutics.

[14]  D. Diamond,et al.  Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review , 2016, BMJ Open.

[15]  P. Sham,et al.  Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese , 2015, Nature Communications.

[16]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[17]  C. Gieger,et al.  Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes , 2015, Diabetes Care.

[18]  B. Vergès.  Pathophysiology of diabetic dyslipidaemia: where are we? , 2015, Diabetologia.

[19]  U. Laufs,et al.  Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9) , 2015, Basic Research in Cardiology.

[20]  A. S,et al.  Effect of intensity of cigarette smoking on haematological and lipid parameters. , 2014, Journal of clinical and diagnostic research : JCDR.

[21]  R. Jamal,et al.  Cohort Profile: The Malaysian Cohort (TMC) project: a prospective study of non-communicable diseases in a multi-ethnic population , 2014, International journal of epidemiology.

[22]  V. Chongsuvivatwong,et al.  Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009 , 2014, Journal of lipids.

[23]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[24]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[25]  B. Zilfalil,et al.  Molecular Description of Familial Defective APOB-100 in Malaysia , 2013, Biochemical Genetics.

[26]  R. Mohamed,et al.  Genetic Polymorphisms in LDLR, APOB, PCSK9 and Other Lipid Related Genes Associated with Familial Hypercholesterolemia in Malaysia , 2013, PloS one.

[27]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[28]  Tom R. Gaunt,et al.  Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models , 2012, Human mutation.

[29]  G. Abecasis,et al.  Exome sequencing and complex disease: practical aspects of rare variant association studies , 2012, Human molecular genetics.

[30]  B. Vollmar,et al.  Aging is associated with a shift of fatty metabolism toward lipogenesis. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  T. H. Sasongko,et al.  Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia , 2011, BMC Medical Genetics.

[32]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[33]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[34]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[35]  J. Keller,et al.  Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis , 2010, Current gerontology and geriatrics research.

[36]  A. Soutar.  Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia , 2010, IUBMB life.

[37]  S. Ylä-Herttuala,et al.  Oxysterol Binding Protein Induces Upregulation of SREBP-1c and Enhances Hepatic Lipogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[38]  V. Lohsoonthorn,et al.  Prevalence and risk factors of hypercholesterolemia among Thai men and women receiving health examinations. , 2006, The Southeast Asian journal of tropical medicine and public health.

[39]  B. Khalid,et al.  Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB). , 2006, The Malaysian journal of pathology.

[40]  Jonathan C. Cohen,et al.  Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein , 2001, Science.

[41]  J. Deslypere,et al.  Genetic causes of familial hypercholesterolaemia in a Malaysian population. , 2000, The Medical journal of Malaysia.

[42]  A. Tchernof,et al.  Lipid metabolism in the elderly , 2000, European journal of clinical nutrition.

[43]  J. Viikari,et al.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene. , 1995, American journal of human genetics.

[44]  K. Khoo.  Hereditary Hyperlipidemia in Malaysia: A historical Perspective of Six Decade of Research and Treatment. , 2014, The Medical journal of Malaysia.

[45]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.